Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kamiya Mehla and Pankaj Singh.
Kamiya Mehla
Connection Strength
7.198
Pankaj Singh
  1. LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis. Cancer Res. 2023 06 02; 83(11):1759-1761.
    View in: PubMed
    Score: 0.883
  2. Metabolic Regulation of Macrophage Polarization in Cancer. Trends Cancer. 2019 12; 5(12):822-834.
    View in: PubMed
    Score: 0.689
  3. Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer. Clin Cancer Res. 2020 01 01; 26(1):6-8.
    View in: PubMed
    Score: 0.687
  4. MUC1: a novel metabolic master regulator. Biochim Biophys Acta. 2014 Apr; 1845(2):126-35.
    View in: PubMed
    Score: 0.461
  5. MicroRNAs in pancreatic cancer metabolism. Nat Rev Gastroenterol Hepatol. 2012 Apr 17; 9(6):334-44.
    View in: PubMed
    Score: 0.408
  6. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. Elife. 2024 Jul 08; 12.
    View in: PubMed
    Score: 0.238
  7. Author Correction: Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 May; 26(5):840.
    View in: PubMed
    Score: 0.235
  8. The MUC1-HIF-1a signaling axis regulates pancreatic cancer pathogenesis through polyamine metabolism remodeling. Proc Natl Acad Sci U S A. 2024 Apr 02; 121(14):e2315509121.
    View in: PubMed
    Score: 0.234
  9. Cancer-associated fibroblast-derived acetate promotes pancreatic cancer development by altering polyamine metabolism via the ACSS2-SP1-SAT1 axis. Nat Cell Biol. 2024 Mar 01.
    View in: PubMed
    Score: 0.232
  10. Vitamin B6 competition in the tumor microenvironment hampers antitumor functions of NK cells. Cancer Discov. 2023 Nov 07.
    View in: PubMed
    Score: 0.227
  11. DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation. bioRxiv. 2023 Apr 05.
    View in: PubMed
    Score: 0.218
  12. CD73 induces GM-CSF/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis. Oncogene. 2022 02; 41(7):971-982.
    View in: PubMed
    Score: 0.200
  13. The cholesterol pathway: impact on immunity and cancer. Trends Immunol. 2022 01; 43(1):78-92.
    View in: PubMed
    Score: 0.200
  14. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic Cancer. Mol Cancer Ther. 2021 12; 20(12):2457-2468.
    View in: PubMed
    Score: 0.197
  15. Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. Gastroenterology. 2021 11; 161(5):1584-1600.
    View in: PubMed
    Score: 0.193
  16. SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
    View in: PubMed
    Score: 0.180
  17. Local and systemic immunosuppression in pancreatic cancer: Targeting the stalwarts in tumor's arsenal. Biochim Biophys Acta Rev Cancer. 2020 08; 1874(1):188387.
    View in: PubMed
    Score: 0.180
  18. Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia. Cancer Lett. 2020 08 01; 484:29-39.
    View in: PubMed
    Score: 0.178
  19. Microscale Gene Expression Analysis of Tumor-Associated Macrophages. Sci Rep. 2018 02 05; 8(1):2408.
    View in: PubMed
    Score: 0.153
  20. Evaluation of Macrophage Polarization in Pancreatic Cancer Microenvironment Under Hypoxia. Methods Mol Biol. 2018; 1742:265-276.
    View in: PubMed
    Score: 0.152
  21. Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. Cancer Immunol Immunother. 2018 Mar; 67(3):445-457.
    View in: PubMed
    Score: 0.151
  22. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 09 11; 32(3):392.
    View in: PubMed
    Score: 0.148
  23. MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell. 2017 07 10; 32(1):71-87.e7.
    View in: PubMed
    Score: 0.147
  24. Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth. Oncotarget. 2015 Dec 01; 6(38):41146-61.
    View in: PubMed
    Score: 0.131
  25. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab. 2014; 2:18.
    View in: PubMed
    Score: 0.120
  26. MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proc Natl Acad Sci U S A. 2012 Aug 21; 109(34):13787-92.
    View in: PubMed
    Score: 0.104
  27. Differential expression of metabolic genes in tumor and stromal components of primary and metastatic loci in pancreatic adenocarcinoma. PLoS One. 2012; 7(3):e32996.
    View in: PubMed
    Score: 0.101
  28. Regulation of Aerobic Glycolysis by microRNAs in Cancer. Mol Cell Pharmacol. 2011; 3(3):125-134.
    View in: PubMed
    Score: 0.093
  29. Structure and function of human DnaJ homologue subfamily a member 1 (DNAJA1) and its relationship to pancreatic cancer. Biochemistry. 2014 Mar 04; 53(8):1360-72.
    View in: PubMed
    Score: 0.029
  30. Exome sequencing and advances in crop improvement. Adv Genet. 2012; 79:87-121.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.